H.C. Wainwright maintains Buy rating on Worksport stock amid operational improvements

H.C. Wainwright reiterated its Buy rating and $11.50 price target for Worksport Ltd. (NASDAQ:WKSP), citing a significant disconnect between the stock's 66.1% year-to-date decline and its strong operational improvements. Despite trading at a $20.72 million market cap and below 1x 2026 revenue estimates, the company reported record Q2 2025 revenue, projects Q3 2025 revenue with over 30% gross margins, and expects positive adjusted EBITDA by 2026. This outlook is supported by 232.13% LTM revenue growth, new product launches, and healthy liquidity, suggesting a potential undervaluation given its path to profitability and robust growth trajectory.

Analysis

Worksport Ltd. (NASDAQ:WKSP) presents a significant disconnect between its recent operational performance and its stock valuation, as highlighted by H.C. Wainwright's reiterated Buy rating and $11.50 price target. The company's stock has declined 66.1% year-to-date, in stark contrast to the Russell 2000's 9.2% gain. This underperformance occurs despite strong fundamental improvements, including a record revenue projection for Q3 2025 with gross margins expected to exceed 30.0%, and a reported 114% year-over-year net sales growth in Q2 2025. Gross margins have shown consistent expansion, rising from 17.7% in Q1 to 31.0% in July. The company is trading at a market capitalization of $20.72M, representing less than 1.0 times 2026 Street revenue estimates, which H.C. Wainwright projects could reach approximately $20.0 million in 2025 alone. A path to profitability is outlined, with analysts expecting positive adjusted EBITDA on a quarterly basis as early as 2026, supported by new product launches. While InvestingPro notes a weak overall financial health score, it also confirms healthy liquidity with a current ratio of 2.27, indicating a strong capacity to meet short-term obligations.

Key Decisions for Investors

• Investors should consider the significant valuation gap, with WKSP trading at less than 1.0x 2026 revenue estimates despite a 232% LTM revenue growth and expanding gross margins, suggesting a potential value opportunity if management executes on its growth plan.
• It is critical to monitor the company's upcoming quarterly earnings to verify the sustained revenue growth and margin expansion towards the guided 30% level, as this is the primary catalyst for achieving the projected positive adjusted EBITDA by 2026.
• While the growth narrative is compelling, investors must weigh the positive operational momentum against the stock's severe underperformance and the noted weak financial health score, making the execution on new product monetization in Q4 2025 and into 2026 a key validation point for the bull thesis.